The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Integrase-defective lentiviral vectors: progress and applications
Abstract
Lentiviral vectors (LVs) offer the advantages of a large packaging capacity, broad cell tropism or specific cell-type targeting through pseudotyping, and long-term expression from integrated gene cassettes. However, transgene integration carries a risk of disrupting gene expression through insertional mutagenesis and may not be required for all applications. A non-integrating LV may be beneficial in cases in which transient gene expression is desired. Several recent publications outline the development and initial biological characterization of such vectors. Here, we discuss the potential applications and new directions for the development of integration-defective LVs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, class I mutations are limited in affecting the integrase multimerisation, linear episome processing, and DNA binding [25], as listed in Table 3.”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [25]
In the citing paper
“Class II mutations can be performed by exchanging the standard gag or pol packaging plasmid with an IN mutant strain [25].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [25]
Citations
Cites
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejm200301163480314 · Cited by 1,867
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Hacein-Bey-Abina, S., Garrigue, A., Wang, G. P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35700 · Cited by 1,854
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
Schröder, A. R. W., Shinn, P., Chen, H., Berry, C., Ecker, J. R., & Bushman, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00864-4 · Cited by 1,832
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499
Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003) · Science · doi:10.1126/science.1083413 · Cited by 1,305
Howe, S. J., Mansour, M. R., Schwarzwaelder, K., Bartholomae, C., Hubank, M., Kempski, H., Brugman, M. H., Pike-Overzet, K., Chatters, S. J., de Ridder, D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35798 · Cited by 1,286
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein‐Bey‐Abina, S., Deist, F. L., Carlier, F., Bouneaud, C., Hue, C., de Villartay, J., Thrasher, A. J., Wulffraat, N. M., Sorensen, R., Dupuis‐Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,102
Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences
Mitchell, R., Beitzel, B. F., Schröder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020234 · Cited by 1,002
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845
Maeder, M. L., Thibodeau-Beganny, S., Osiak, A., Wright, D. A., Anthony, R. M., Eichtinger, M., Jiang, T., Foley, J. E., Winfrey, R. J., Townsend, J. A., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.016 · Cited by 727
Self-citationMontini, E., Cesana, D., Schmidt, M., Sanvito, F., Bartholomae, C. C., Ranzani, M., Benedicenti, F., Sergi, L. S., Ambrosi, A., Ponzoni, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37630 · Cited by 571
Kulkosky, J., Jones, K. S., Katz, R. A., Mack, J. P. G., & Skalka, A. M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2331 · Cited by 567
Katz, R. A., & Skalka, A. M. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.001025 · Cited by 524
Engelman, A., & Craigie, R. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6361-6369.1992 · Cited by 519
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C., & Bushman, F. D. (2007) · Genome Research · doi:10.1101/gr.6286907 · Cited by 457
Systematic Determination of the Packaging Limit of Lentiviral Vectors
Kumar, M., Keller, B. C., Makalou, N., & Sutton, R. E. (2001) · Human Gene Therapy · doi:10.1089/104303401753153947 · Cited by 456
Inhibition of influenza virus production in virus-infected mice by RNA interference
Ge, Q., Filip, L., Bai, A., Nguyen, T., Eisen, H. N., & Chen, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402486101 · Cited by 443
Craigie, R., Fujiwara, T., & Bushman, F. (1990) · Cell · doi:10.1016/0092-8674(90)90126-y · Cited by 409
Role of the non‐homologous DNA end joining pathway in the early steps of retroviral infection
Li, L., Olvera, J. M., Yoder, K., Mitchell, R., Butler, S., Lieber, M., Martin, S. L., & Bushman, F. D. (2001) · EMBO Journal · doi:10.1093/emboj/20.12.3272 · Cited by 386
Nucleotide sequence and genomic organization of feline immunodeficiency virus.
Talbott, R. L., Sparger, E. E., Lovelace, K., Fitch, W. M., Pedersen, N. C., Luciw, P. A., & Elder, J. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5743 · Cited by 383
Sinn, P., Sauter, S., & McCray, P. B. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302570 · Cited by 351
Self-citationEngelman, A., Bushman, F. D., & Craigie, R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05996.x · Cited by 350
Katz, R. A., Merkel, G., Kulkosky, J., Leis, J., & Skalka, A. M. (1990) · Cell · doi:10.1016/0092-8674(90)90290-u · Cited by 346
Retroviral integrase domains: DNA binding and the recognition of LTR sequences
Khan, E., Mack, J. P. G., Katz, R. A., Kulkosky, J., & Skalka, A. M. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.4.851 · Cited by 287
HIV Integrase, a Brief Overview from Chemistry to Therapeutics*
Craigie, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100027200 · Cited by 277
Wiskerchen, M. A., & Muesing, M. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.376-386.1995 · Cited by 271
Engelman, A., Hickman, A. B., & Craigie, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5911-5917.1994 · Cited by 250
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249
Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles
Butler, S. L., Johnson, E. P., & Bushman, F. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3739-3747.2002 · Cited by 237
Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo
Chen, Z. Y., He, C. Y., Meuse, L. A., & Kay, M. A. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302231 · Cited by 232
Leavitt, A. D., Robles, G., Alesandro, N., & Varmus, H. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.721-728.1996 · Cited by 232
Early steps of retrovirus replicative cycle
Nisole, S., & Saı̈b, A. (2004) · Retrovirology · doi:10.1186/1742-4690-1-9 · Cited by 230
Repair of gaps in retroviral DNA integration intermediates
Yoder, K. E., & Bushman, F. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11191-11200.2000 · Cited by 209
Integration is not necessary for expression of human immunodeficiency virus type 1 protein products
Stevenson, M., Haggerty, S., Lamonica, C. A., Meier, C. M., Welch, S. K., & Wasiak, A. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2421-2425.1990 · Cited by 206
Drelich, M., Wilhelm, R., & Mous, J. (1992) · Virology · doi:10.1016/0042-6822(92)90499-f · Cited by 206
Leavitt, A. D., Shiue, L., & VARMUS, H. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53969-7 · Cited by 200
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Nightingale, S. J., Hollis, R. P., Pepper, K. A., Petersen, D., Yu, X.-J., Yang, C., Bahner, I., & Kohn, D. B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.008 · Cited by 192
Pierson, T. C., Kieffer, T. L., Ruff, C. T., Buck, C. B., Gange, S. J., & Siliciano, R. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4138-4144.2002 · Cited by 184
Stable Gene Transfer to Muscle Using Non-integrating Lentiviral Vectors
Apolonia, L., Waddington, S. N., Fernandes, C., Ward, N. J., Bouma, G., Blundell, M. P., Thrasher, A. J., Collins, M. K., & Philpott, N. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300281 · Cited by 174
Therapeutic levels of human factor VIII and IX using HIV-1–based lentiviral vectors in mouse liver
Park, F., Ohashi, K., & Kay, M. A. (2000) · Blood · doi:10.1182/blood.v96.3.1173 · Cited by 157
Polynucleotidyl transfer reactions in transpositional DNA recombination.
Mizuuchi, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36600-1 · Cited by 155
Ellison, V., & Brown, P. O. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7316 · Cited by 154
Circularization of human immunodeficiency virus type 1 DNA in vitro
Farnet, C. M., & Haseltine, W. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6942-6952.1991 · Cited by 148
Novel Integrase-Defective Lentiviral Episomal Vectors for Gene Transfer
Vargas, J., Gusella, G. L., Najfeld, V., Klotman, M., & Cara, A. (2004) · Human Gene Therapy · doi:10.1089/104303404322959515 · Cited by 132
Ellison, V., Gerton, J. L., Vincent, K. A., & Brown, P. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3320 · Cited by 131
Retroviral vectors: new applications for an old tool
Barquinero, J., Eixarch, H., & Pérez-Melgosa, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302363 · Cited by 127
Lutzke, R. A. P., & Plasterk, R. H. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4841-4848.1998 · Cited by 124
HIV-1 gene expression: lessons from provirus and non-integrated DNA
Wu, Y. (2004) · Retrovirology · doi:10.1186/1742-4690-1-13 · Cited by 124
Saenz, D. T., Loewen, N. A., Peretz, M., Whitwam, T., Barraza, R., Howell, K. G., Holmes, J. M., Good, M. S., & Poeschla, E. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2906-2920.2004 · Cited by 122
Intramolecular integration within Moloney murine leukemia virus DNA
Shoemaker, C. B., Hoffman, J., Goff, S. P., & Baltimore, D. (1981) · Journal of Virology · doi:10.1128/jvi.40.1.164-172.1981 · Cited by 121
Gene Silencing by Small Regulatory RNAs in Mammalian Cells
Scherr, M., & Eder, M. (2007) · Cell Cycle · doi:10.4161/cc.6.4.3807 · Cited by 117
Hacein‐Bey‐Abina, S., Deist, F. L., Carlier, F., Bouneaud, C., Hue, C., Villartay, J. D., Thrasher, A. J., Wulffraat, N. M., Sorensen, R. J. D., Dupuis‐Girod, S., et al. (2002) · UCL Discovery (University College London) · Cited by 117
Nakajima, N., Lu, R., & Engelman, A. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7944-7955.2001 · Cited by 113
CCR5: no longer a ‘good for nothing’ gene – chemokine control of West Nile virus infection
Lim, J. K., Glass, W. G., McDermott, D. H., & Murphy, P. M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.05.007 · Cited by 112
Targeted Genome Modifications Using Integrase-deficient Lentiviral Vectors
Cornu, T. I., & Cathomen, T. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300345 · Cited by 105
Retrovirus Vectors: Toward the Plentivirus?
Baum, C., Schambach, A., Bohne, J., & Galla, M. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.007 · Cited by 103
Minicircle‐DNA production by site specific recombination and protein–DNA interaction chromatography
Mayrhofer, P., Blaesen, M., Schleef, M., & Jechlinger, W. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1243 · Cited by 102
Rahim, A. A., Wong, A. M. S., Howe, S. J., Buckley, S. M. K., Acosta-Saltos, A. D., Elston, K. E., Ward, N. J., Philpott, N. J., Cooper, J. D., Anderson, P. N., et al. (2009) · Gene Therapy · doi:10.1038/gt.2008.186 · Cited by 101
Rodrigues, T., Carrondo, M. J. T., Alves, P. M., & Cruz, P. E. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.07.028 · Cited by 98
Miller, M. D., Wang, B., & Bushman, F. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3938-3944.1995 · Cited by 96
Hybrid Lentivirus-transposon Vectors with a Random Integration Profile in Human Cells
Staunstrup, N. H., Moldt, B., Mátés, L., Villesen, P., Jakobsen, M., Ivics, Z., Izsvák, Z., & Mikkelsen, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.10 · Cited by 96
A Large U3 Deletion Causes Increased In Vivo Expression from a Nonintegrating Lentiviral Vector
Bayer, M., Kantor, B., Cockrell, A., Ma, H., Zeithaml, B., Li, X., McCown, T., & Kafri, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.199 · Cited by 94
Evidence for Gene Expression by Unintegrated Human Immunodeficiency Virus Type 1 DNA Species
Brussel, A., & Sonigo, P. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11263-11271.2004 · Cited by 93
Lu, R., Limón, A., Ghory, H. Z., & Engelman, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2493-2505.2005 · Cited by 92
Successful Immunization with a Single Injection of Non-integrating Lentiviral Vector
Negri, D. R., Michelini, Z., Baroncelli, S., Spada, M., Vendetti, S., Buffa, V., Bona, R., Leone, P., Klotman, M. E., & Cara, A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300241 · Cited by 84
2-LTR Circular Viral DNA as a Marker for Human Immunodeficiency Virus Type 1 Infection in Vivo
Pauza, C. D., Trivedi, P., McKechnie, T. S., Richman, D. D., & Graziano, F. M. (1994) · Virology · doi:10.1006/viro.1994.1667 · Cited by 81
Sleeping Beauty Transposition From Nonintegrating Lentivirus
Vink, C. A., Gaspar, H. B., Gabriel, R., Schmidt, M., McIvor, R. S., Thrasher, A. J., & Qasim, W. (2009) · Molecular Therapy · doi:10.1038/mt.2009.94 · Cited by 76
Central Core Domain of Retroviral Integrase Is Responsible for Target Site Selection
hio Shibagaki, Y., & Chow, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8361 · Cited by 73
Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
Coutant, F., Frenkiel, M.-P., Despres, P., & Charneau, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003973 · Cited by 70
Expressing short hairpin RNAs in vivo
Snøve, O., & Rossi, J. J. (2006) · Nature Methods · doi:10.1038/nmeth927 · Cited by 64
Métais, J., & Dunbar, C. E. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300372 · Cited by 64
Mairhofer, J., & Grabherr, R. M. (2008) · Molecular Biotechnology · doi:10.1007/s12033-008-9046-7 · Cited by 63
Toolbox for retrovectorologists
Pagès, J., & Bru, T. (2004) · Journal of Gene Medicine · doi:10.1002/jgm.498 · Cited by 60
RNA Interference: A Tool for Querying Nervous System Function and an Emerging Therapy
Davidson, B. L., & Boudreau, R. L. (2007) · Neuron · doi:10.1016/j.neuron.2007.02.020 · Cited by 56
Integration Site Choice of a Feline Immunodeficiency Virus Vector
Kang, Y.-B., Moressi, C. J., Scheetz, T., Xie, L.-T., Tran, D., Casavant, T., Ak, P., Benham, C., Davidson, B., & McCray, P. (2006) · Journal of Virology · doi:10.1128/jvi.00719-06 · Cited by 53
Self-citationGaur, M., & Leavitt, A. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4678-4685.1998 · Cited by 52
Characterization of Feline Immunodeficiency Virus Integrase and Analysis of Functional Domains
Shibagaki, Y., Holmes, M. L., Appa, R. S., & Chow, S. A. (1997) · Virology · doi:10.1006/viro.1997.8466 · Cited by 50
van Gent, D. C., Groeneger, A. A. M. O., & Plasterk, R. H. A. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.15.3373 · Cited by 50
Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase
Moldt, B., Staunstrup, N. H., Jakobsen, M., Yáñez-Muñoz, R. J., & Mikkelsen, J. G. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-60 · Cited by 44
Loewen, N. A., Leske, D. A., Chen, Y., Teo, W., Saenz, D. T., Peretz, M., Holmes, J. M., & Poeschla, E. M. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.447 · Cited by 36
Targeted gene modification in mouse ES cells using integrase‐defective lentiviral vectors
Okada, Y., Ueshin, Y., Hasuwa, H., Takumi, K., Okabe, M., & Ikawa, M. (2009) · genesis · doi:10.1002/dvg.20469 · Cited by 24
Transient gene expression mediated by integrase-defective retroviral vectors.
Yu, S.-S., Dan, K., Chono, H., Chatani, E., Mineno, J., & Kato, I. (2008) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2008.02.012 · Cited by 18
Conditionally replicating lentiviral-hybrid episomal vectors for suicide gene therapy.
Vargas, J. J., Klotman, M., & Cara, A. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.06.015 · Cited by 17
Js, N. (1999) · PubMed · Cited by 3
Research works printed but not linked: 2
- Goff SP . Retroviridae: the retroviruses and their replication. In: David M Knipe PMH, Diane E Griffin, Malcolm A Martin, Robert A Lamb, Bernard Roizman, Stephen E Strauss (ed). Fields Virology, 4th edn, vol. 2. Lippincott Williams & Wilkins: Philadelphia, 2001. pp 1871–1940.
- Lombardo A, Cesana D, Genovese P, Provasi E, Maruggi G, Binini C et al. Characterization of potential genomic ‘safe harbor’ for efficient targeted gene addition with zinc finger nucleases. Mol Ther 2009; 17: S168.
Cited by
Sorted by citations
Recent Advances in CRISPR/Cas9 Delivery Strategies
Yip, B. (2020) · Biomolecules · doi:10.3390/biom10060839 · Cited by 292
Kaufmann, K. B., Büning, H., Galy, A. H. M., Schambach, A., & Grez, M. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202287 · Cited by 300
Engineering mesenchymal stem cells for regenerative medicine and drug delivery
Park, J. S., Suryaprakash, S., Lao, Y., & Leong, K. W. (2015) · Methods · doi:10.1016/j.ymeth.2015.03.002 · Cited by 252
Improving the safety of cell therapy products by suicide gene transfer
Jones, B. S., Lamb, L. S., Goldman, F. D., & Stasi, A. D. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00254 · Cited by 206
The role of unintegrated DNA in HIV infection
Sloan, R. D., & Wainberg, M. A. (2011) · Retrovirology · doi:10.1186/1742-4690-8-52 · Cited by 155
Metadata
- Authors
- Banasik, M. B., & McCray, P. B.
- Affiliations
- University of Iowa (US)
- Corresponding author
- McCray, P B
- ORCID
- McCray, P B
- Venue
- Gene Therapy
- Published
- 2009-10-22
- Volume
- 17
- Issue
- 2
- Pages
- 150-157
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W1964810194
- Cited by
- 129
- References
- 87
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 2 · 2017: 5 · 2016: 10 · 2015: 10 · 2014: 16 · 2013: 8 · 2012: 17
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Keywords
- lentiviral vectors, non-integrating vectors, insertional mutagenesis, transient expression, pseudotyping, cell tropism, gene therapy vectors
- MeSH terms
- Animals, Genetic Vectors, Genetic Therapy, Gene Expression, Lentivirus, Mutagenesis, Insertional, Virus Integration, Gene Transfer Techniques, Transgenes, Integrases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review